Authors
Latest:
Fostering Equity in Health Care Research: Eliminating Gender Bias With Decentralized Clinical Trials for WomenDecentralized clinical trials are emerging as a method by which to address gender bias in clinical research.
Latest:
Pharmacists Have a Significant Role in Chronic Kidney DiseaseThe Kidney Disease: Improving Global Outcomes guidelines can provide pharmacists with approaches to minimizing chronic kidney disease progression and complications.
Latest:
2030: The Beginning of a New Era in Health CareBy setting a standard for prescriptions that improves member access, outcomes, and experience, we will establish a path forward for every facet of health care.
Latest:
Case Studies in PharmacogenomicsThe potential to optimize medication efficacy and safety across diverse populations is garnering attention in various health care settings.
Latest:
Medication Compliance When Treating CKD is Crucial, UPMC Health Plan Expert SaysHelping patients adhere to their medications to manage their chronic kidney disease (CKD) and comorbidities is one of the key areas pharmacists should prioritize.
Latest:
From Inpatient to Outpatient: A Pharmacy-Led Evolution in Transplant CareErin Lexner, PharmD, BCPS, discussed her team’s experience transitioning to outpatient BEAM from inpatient CBV.
Latest:
Locking Prescription Vials Helps Keep Medicine Safe in Medication-assisted Treatment ProgramsFor patients with opioid use disorder, medication-assisted treatment programs are a clinically effective approach.
Latest:
The Term 'Bispecific Antibody' Is No Longer EnoughBispecific therapies require clearer terminology to improve safety and communication.
Latest:
Removing Mesna From Cyclophosphamide Cycles in VAdriaC-IE for Ewing SarcomaThis retrospective cohort study provides preliminary evidence for safe removal of mesna from VAdriaC cycles, as the incidence of hemorrhagic cystitis did not increase in patients with Ewing sarcoma who received cyclophosphamide without prophylactic mesna.
Latest:
The Power of Our Voice: Why Pharmacists Must Advocate for Our ProfessionAdvocacy ensures that policymakers understand the realities on the ground. If we fail to speak up, decisions about our profession will be made without our input—often by individuals who lack the expertise and perspective we bring to the table.
Latest:
Breaking New Ground: Emerging Therapies for Treatment of EGFR-Positive NSCLCA panelist discusses how emerging advancements in non–small cell lung cancer (NSCLC) treatment include the anticipated FDA approval of subcutaneous amivantamab, which would significantly reduce infusion-related reactions seen in the MARIPOSA trials while improving patient experience and reducing infusion center chair time, as well as promising antibody-drug conjugates like sacituzumab govitecan (Trodelvy) that may provide better first and second-line treatment options with potentially less toxicity than current standard regimens.
Latest:
Pharmacists Have a Significant Role in Chronic Kidney DiseaseThe Kidney Disease: Improving Global Outcomes guidelines can provide pharmacists with approaches to minimizing chronic kidney disease progression and complications.
Latest:
Paradoxical Hypotension After Inadvertent Intravenous Administration of EpinephrineRaising awareness of the potentially fatal cardiovascular complications of epinephrine toxicity.
Latest:
Is It Too Late to Get a Flu Shot?Ideally, older patients receive vaccinations by October, but disease activity often peaks in February or March.
Latest:
Pharmacists’ Role in Antibiotic Stewardship: Understanding Spectrums to Combat ResistancePharmacists ensure responsible antibiotic use, combating resistance through tailored therapies.
Latest:
New Frontline BTK Inhibitor Strategy Gains FDA Approval in Untreated Mantle Cell LymphomaThe FDA approved acalabrutinib as a frontline option for untreated mantle cell lymphoma.
Latest:
As Part of the Clinical Care Team, Pharmacists Can Enable Greater Medication Access, Boost Adherence, and Improve Health OutcomesPharmacists today are an integral part of a patient’s care journey, providing clinical expertise and support that improves medication adherence, increases access to medication and advances health outcomes.
Latest:
FDA Is Evaluating the Prospect of Removing Phenylephrine From OTC ShelvesOral phenylephrine is a common ingredient in OTC products, but its clinical efficacy is questionable. The FDA is considering removing it from the market.
Latest:
Effort Is Needed to Address Climate Change-Associated Cancer Risk in the United StatesThe data show that the 10-year survival rate of patients with breast cancer who survived Hurricane Katrina was much lower than those who did not face a major weather event.
Latest:
Access to Medicine, Clinical Trials Jeopardized by Ukraine WarThere are a huge number of medical facilities in Ukraine that run international clinical trials, with the FDA noting that more than 250 drugs and devices were undergoing clinical research in Ukraine.
Latest:
Community Pharmacists and Technicians: Impacting Public Health One Service at a TimeCommunity-based pharmacy services are reaching new heights as pharmacists and pharmacy technicians are able to have a larger impact on patient care than ever before.
Latest:
Pediatric Weight is Crucial to Perfecting the DoseEvidence indicates that up to 25% of all prescriptions for children could be dosed inappropriately, making it the most common type of medication administration error.
Latest:
Focus on Human Papillomavirus Virus Vaccination in Adults and Young AdultsCombining strong evidence-based recommendations with caring, compassionate, and frequent counseling opportunities hopefully will increase vaccine acceptance and ultimately reduce the incidence of HPV and associated cancers among our patients.
Latest:
Gabapentin Presents High Potential for MisuseAlthough the anticonvulsant is not considered a controlled substance, some state legislation focuses on monitoring the use of or reclassifying it.
Latest:
Future Management Considerations of RSVPanelists discuss the evolving management of RSV, highlighting the importance of increasing awareness and education, anticipating advances in testing, data reporting, and treatment options like monoclonal antibodies and antivirals, and considering future vaccination strategies such as booster doses to enhance prevention and patient outcomes.
Latest:
Survey-Based Analysis of Pharmacogenomics Education IntegrationGaps in curricula emphasize a need for enhanced interprofessional training to improve patient care.
Latest:
Clinical Overview: Lecanemab Use, Coverage for Alzheimer DiseaseIn clinical trials, lecanemab showed a reduction of amyloid beta plaque in patients with Alzheimer disease.
Latest:
For Optimal Bioavailability, Administer Dronedarone With a Complete MealBioavailability of dronedarone is markedly increased when administered with food. To maximize absorption, patients should take dronedarone with a complete meal (ideally >500 calories).
Latest:
In a Nod to Precision Oncology, the FDA Approves RevumenibThe approval marks a significant milestone in the treatment of a rare and aggressive subtype of acute leukemia.
Latest:
Targeting the Untargetable: Novel Agents in Acute Myeloid LeukemiaPharmacists have an important role in the optimization of AML therapies.
